STOCK TITAN

Orthofix Medical Inc. (OFIX) exec sells 3,670 shares for tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Orthofix Medical Inc. executive Aviva McPherron reported selling 3,670 shares of common stock at $9.38 per share on an open market transaction. According to the footnote, the sale was mandated to satisfy tax withholding for restricted stock unit settlement under a pre-approved sell-to-cover program. McPherron still holds 66,330 shares directly, including 44,748 restricted stock units and 2,147 shares acquired through Orthofix’s Stock Purchase Plan.

Positive

  • None.

Negative

  • None.
Insider McPherron Aviva
Role Pres, Global Ops & Qual
Sold 3,670 shs ($34K)
Type Security Shares Price Value
Sale Common Stock 3,670 $9.38 $34K
Holdings After Transaction: Common Stock — 66,330 shares (Direct, null)
Footnotes (1)
  1. Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Shares sold 3,670 shares Open-market sale on 2026-06-18 to satisfy tax withholding
Sale price $9.38 per share Price for McPherron’s 3,670-share sale
Shares after transaction 66,330 shares Direct holdings following the reported sale
Restricted stock units 44,748 units Previously reported RSUs included in post-transaction holdings
Shares from Stock Purchase Plan 2,147 shares Acquired under Orthofix’s SPP on 04/30/2026
Net shares sold 3,670 shares Net sell direction per transaction summary
sell-to-cover requirement financial
"pursuant to a pre-existing sell-to-cover requirement previously approved and mandated"
restricted stock units financial
"in connection with the settlement of restricted stock units, pursuant to a pre-existing"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Purchase Plan financial
"shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026"
A stock purchase plan is a company-run program that lets employees or qualifying investors buy the company’s shares regularly, often through paycheck deductions and sometimes at a discounted price or with matching contributions. It matters because it encourages ownership—like a workplace discount for buying company products—aligning interests between holders and managers, while affecting share supply and potential value for outside investors.
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)."
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McPherron Aviva

(Last)(First)(Middle)
3451 PLANO PARKWAY

(Street)
LEWISVILLE TEXAS 75056

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Pres, Global Ops & Qual
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026S(1)3,670D$9.3866,330(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
2. Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
/s/ J. Andres Cedron, attorney-in-fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Orthofix Medical (OFIX) report for Aviva McPherron?

Orthofix reported that Aviva McPherron sold 3,670 shares of common stock. The shares were sold at $9.38 each to cover tax withholding related to the settlement of restricted stock units under a pre-approved sell-to-cover requirement.

Why did Aviva McPherron sell Orthofix Medical (OFIX) shares?

The sale was executed to satisfy tax withholding obligations tied to restricted stock unit settlement. A pre-existing sell-to-cover requirement, mandated by the board’s compensation committee, required this transaction and left McPherron with no discretion over timing or amount.

How many Orthofix Medical (OFIX) shares does Aviva McPherron hold after the sale?

After the transaction, Aviva McPherron holds 66,330 shares of Orthofix common stock directly. This figure includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix’s Stock Purchase Plan on April 30, 2026.

Was Aviva McPherron’s Orthofix (OFIX) stock sale a discretionary trade?

No, the filing states the sale was made under a pre-existing sell-to-cover requirement. It was approved and mandated by the board’s compensation committee, meaning McPherron did not exercise discretion over executing this transaction in the market.

What role does Aviva McPherron hold at Orthofix Medical (OFIX)?

Aviva McPherron is identified as an officer of Orthofix, serving as President, Global Operations & Quality. Her reported holdings and transactions relate to common stock and restricted stock units granted under the company’s equity compensation arrangements.

What is Orthofix Medical’s Stock Purchase Plan (SPP) mentioned in the filing?

The Stock Purchase Plan, referred to as Orthofix’s SPP, is described as a “Stock Purchase Plan” under Rule 16b-3(b)(5). According to the filing, 2,147 shares were acquired under this plan and such acquisitions are exempt from Section 16(b) short-swing profit rules.